http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104693171-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_320d62d5a1756969b78279df21ba05c7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38 |
| filingDate | 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfbf7b8c245249b1cdf7c9c4d96df8a4 |
| publicationDate | 2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104693171-A |
| titleOfInvention | Methoxyphenyl-containing thiophene amide structured double-target-point inhibitor and use thereof |
| abstract | The invention relates to the field of type 2 diabetes related medicines and particularly relates to an alkoxyphenyl-containing thiophene amide structured SGLT2/SGLT1 double-target-point inhibitor, a preparation method thereof and application of the double-target-point inhibitor in preparation of the type 2 diabetes related medicines. The double-target-point inhibitor has a structure represented by a formula shown in descriptions, wherein X is selected from halogen substituents. |
| priorityDate | 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.